drug · protein
patient view →bintrafusp alfa
Phase 2updated 2mo agoby Merck KGaA🔗 ChEMBL
Phase 2community read0 votes
Protein drug with a maximum clinical stage of Phase 3 (across all indications), with 16 investigational indications.
targets
Programmed cell death 1 ligand 1Transforming growth factor beta
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that